Band 2
Provided by Xudong Tao
Mr. Tao has over 25 years of experience practicing law in the PRC, focusing on debt and equity financing by PRC companies in both domestic and overseas markets, including advising issuers, underwriters and investors in connection with IPO and listing on the capital markets of the PRC, Hong Kong and USA, and post-listing restructuring, mergers and acquisitions, take-private and re-listing transactions.
Mr. Tao’s most recent representative deals include: (a) acting as PRC counsel to Grifols S.A. in its strategic investment in SSE-listed SRAAS in 2018 and divest in 2024; (b) acting as the issuer or underwriter’s PRC counsel to the HKIPO and listing on HKEX by QuantumParm, Qyun Therapeutics (2024), JF Wealth, DPC Dash (2023), AIM Vaccine (2022) and Microport Medbot (2021); (c) acting as the issuer’s counsel to IPO in the PRC and listing on PRC STAR Market by Biokin Pharma (2023), Hinova Pharma, Transwarp (2022), BeiGene (2021), Zelgen Biopharma and HitGen (2020), etc.
Mr. Tao has been selected as “Leading Lawyer” in capital market and mergers and acquisitions areas by Asialaw and IFLR since 2012. He is also ranked as a “Recommended Lawyer” by Chambers in corporate and commercial area (Band I) and a “Stand-out Lawyers” by Thomson Reuters in 2021.
Member of the All China Bar Association
Provided by Chambers
Provided by Chambers
Tao Xudong is very professional and speaks great English, which is indispensable for dealing with cross-border matters and related documentation.
陶旭东律师非常专业，英语说得很好，这对于处理跨境事务和相关文件是必不可少的。
Tao Xudong is very professional and speaks great English, which is indispensable for dealing with cross-border matters and related documentation.
陶旭东律师非常专业，英语说得很好，这对于处理跨境事务和相关文件是必不可少的。
7 items provided by JunHe LLP
Four JunHe Cases Make the List of Belt and Road Legal Service Typical Cases
On September 8, the 2024 Results Release Session of the Typical Cases of the Belt and Road Legal Service was held in Xiamen, Fujian Province. It was hosted by the Belt and Road Legal Research Center of the China University of Political Science and Law and supported by Legal Daily and legaldaily.com.
JunHe Advises Planet Image on its NASDAQ Listing
On January 25, 2024, Planet Image International Limited (“Planet Image” or the “Company”) was successfully listed on the NASDAQ, with the ticker symbol “YIBO”.
JunHe Advises Qyuns on its Listing on the Stock Exchange of Hong Kong
On Mar. 20, 2024, Qyuns Therapeutics (02509.HK) issued 12,046,400 H shares globally and listed on the HK Stock Exchange's Main Board. It's the first in its biopharmaceutical niche and under Chapter 18A to list in HK after the New Rules for Overseas Listing.
JunHe Advises Zhaojin Mining on its HK$1.7 Billion H Share Placement
On April 22, 2024, Zhaojin Mining (1818.HK) completed a placement of 132m new H shares at HK$13.20, raising about HK$1.74bn , marking the largest such placement in the non-ferrous metals industry in Hong Kong since 2022.
JunHe helps QuantumPharm become the first to list on HKEX under new Chapter 18C rules
On 13 June 2024, QuantumPharm Inc. was listed on the Main Board of the Hong Kong Stock Exchange. QuantumPharm is the first stock to be listed under Chapter 18C of the New Rules Governing the Listing of Specialized Technology Companies on the Hong Kong Stock Exchange.
JunHe guides Grifols in SRAAS equity sale and Haier alliance
On June 18, 2024, Grifols sold a 20% stake in SRAAS to Haier Group for RMB 12.5 billion, retaining a 6.58% stake and forming a strategic alliance with Haier and SRAAS. (Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group).
JunHe Assists SDIC Juli in Strategic Investment in Moon Biotech
Recently, SDIC Juli Investment Management Co., Ltd. ("SDIC Juli") completed a strategic investment of nearly RMB 300 million in Moon (Guangzhou) Biotech Co., Ltd. ("Moon Biotech").
Four JunHe Cases Make the List of Belt and Road Legal Service Typical Cases
On September 8, the 2024 Results Release Session of the Typical Cases of the Belt and Road Legal Service was held in Xiamen, Fujian Province. It was hosted by the Belt and Road Legal Research Center of the China University of Political Science and Law and supported by Legal Daily and legaldaily.com.
JunHe Advises Planet Image on its NASDAQ Listing
On January 25, 2024, Planet Image International Limited (“Planet Image” or the “Company”) was successfully listed on the NASDAQ, with the ticker symbol “YIBO”.
JunHe Advises Qyuns on its Listing on the Stock Exchange of Hong Kong
On Mar. 20, 2024, Qyuns Therapeutics (02509.HK) issued 12,046,400 H shares globally and listed on the HK Stock Exchange's Main Board. It's the first in its biopharmaceutical niche and under Chapter 18A to list in HK after the New Rules for Overseas Listing.
JunHe Advises Zhaojin Mining on its HK$1.7 Billion H Share Placement
On April 22, 2024, Zhaojin Mining (1818.HK) completed a placement of 132m new H shares at HK$13.20, raising about HK$1.74bn , marking the largest such placement in the non-ferrous metals industry in Hong Kong since 2022.
JunHe helps QuantumPharm become the first to list on HKEX under new Chapter 18C rules
On 13 June 2024, QuantumPharm Inc. was listed on the Main Board of the Hong Kong Stock Exchange. QuantumPharm is the first stock to be listed under Chapter 18C of the New Rules Governing the Listing of Specialized Technology Companies on the Hong Kong Stock Exchange.
JunHe guides Grifols in SRAAS equity sale and Haier alliance
On June 18, 2024, Grifols sold a 20% stake in SRAAS to Haier Group for RMB 12.5 billion, retaining a 6.58% stake and forming a strategic alliance with Haier and SRAAS. (Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group).
JunHe Assists SDIC Juli in Strategic Investment in Moon Biotech
Recently, SDIC Juli Investment Management Co., Ltd. ("SDIC Juli") completed a strategic investment of nearly RMB 300 million in Moon (Guangzhou) Biotech Co., Ltd. ("Moon Biotech").
